tofacitinib
Showing 26 - 50 of 67
Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,
Active, not recruiting
- Neoplasms With Mesothelin Expression
- +3 more
- LMB-100
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2022
Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)
Recruiting
- Rheumatoid Arthritis
- TLL-018
- Tofacitinib
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 7, 2022
ive Alzheimer's Medicines (DREAM) - Tofacitinib vs Abatacept
Completed
- Rheumatoid Arthritis
- Tofacitinib
- Abatacept
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 15, 2021
Rheumatic Arthritis Trial in Germany (Tofacitinib, Etanercept)
Recruiting
- Rheumatic Arthritis
- Tofacitinib
- Etanercept
-
Berlin, Germany
- +5 more
Mar 1, 2022
ANCA Associated Vasculitis, Drug Use, JAK-STAT Pathway Deregulation Trial in Shanghai (Tofacitinib)
Completed
- ANCA Associated Vasculitis
- +2 more
- Tofacitinib
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 20, 2021
Granulomatosis With Polyangiitis Trial in Shanghai (Tofacitinib, Methotrexate)
Recruiting
- Granulomatosis With Polyangiitis
- Tofacitinib
- Methotrexate
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 5, 2021
Rheumatoid Arthritis Trial in Hangzhou (Tofacitinib)
Recruiting
- Rheumatoid Arthritis
- Tofacitinib
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 9, 2021
Idiopathic Inflammatory Myopathies Trial in Beijing (tofacitinib)
Recruiting
- Idiopathic Inflammatory Myopathies
- tofacitinib
-
Beijing, Beijing, ChinaDepartment of Rheumatology and Immunology, Peking University Peo
Oct 9, 2022
Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Tofacitinib, Pred)
Recruiting
- Arthritis, Rheumatoid
- Iguratimod
- +2 more
-
Jinan, Shandong, ChinaQilu Hospital
Jun 17, 2021
Rheumatoid Arthritis Trial in London (Etanercept, tofacitinib)
Recruiting
- Rheumatoid Arthritis
- Etanercept
- tofacitinib
-
London, Ontario, CanadaRheumatology Clinic, St. Joseph's Health Care
May 10, 2022
COVID-19 Trial in Moscow (Tofacitinib)
Completed
- COVID-19
- Tofacitinib
-
Moscow, Russian FederationSechenov First Moscow State Medical University (Sechenov Univers
Feb 11, 2021
Uveitis, Scleritis Trial in Saint Louis (tofacitinib)
Unknown status
- Uveitis
- Scleritis
- tofacitinib
-
Saint Louis, MissouriWashington University in Saint Louis
Jan 7, 2021
Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)
Recruiting
- Psoriatic Arthritis
- +2 more
- Prednisolone
- +14 more
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen
Nov 10, 2022
Dermatomyositis Trial in Baltimore (Tofacitinib)
Completed
- Dermatomyositis
- Tofacitinib
-
Baltimore, MarylandJohns Hopkins University
Nov 5, 2020
Healthy Trial in Merksem (Tofacitinib)
Completed
- Healthy
- Tofacitinib
-
Merksem, BelgiumClinical Pharmacology Unit
Oct 26, 2021
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)
Recruiting
- Rheumatoid Arthritis
- +2 more
- Upadacitinib
- +7 more
-
Birmingham, Alabama
- +7 more
Sep 19, 2022
Rheumatoid Arthritis Trial in Seoul (Tofacitinib)
Unknown status
- Rheumatoid Arthritis
- Tofacitinib
-
Seoul, Korea, Republic ofHanyang University
Jun 23, 2020
Juvenile Idiopathic Arthritis Trial in Worldwide (Tofacitinib)
Recruiting
- Juvenile Idiopathic Arthritis
- Tofacitinib
-
Phoenix, Arizona
- +134 more
Jan 25, 2023
Rheumatoid Arthritis Trial in Dhaka (Methotrexate, Tofacitinib)
Unknown status
- Rheumatoid Arthritis
- Methotrexate
- Tofacitinib
-
Dhaka, BangladeshBangabandhu Seikh Mujib Medical University
Jul 6, 2020
Ulcerative Colitis Trial in Worldwide (tofacitinib)
Recruiting
- Ulcerative Colitis
- tofacitinib
-
Phoenix, Arizona
- +92 more
Jan 25, 2023
COVID-19 Trial in United States (Tofacitinib, Placebo)
Withdrawn
- COVID-19
- Tofacitinib
- Placebo
-
Hartford, Connecticut
- +5 more
Jul 29, 2020
Systemic Sclerosis, Scleroderma Trial in Ann Arbor, Pittsburgh (Tofacitinib, Placebo Oral Tablet)
Completed
- Systemic Sclerosis
- Scleroderma
- Tofacitinib
- Placebo Oral Tablet
-
Ann Arbor, Michigan
- +1 more
Apr 28, 2020
SARS-COv2 Related Interstitial Pneumonia Trial in Ancona (Tofacitinib)
Unknown status
- SARS-COv2 Related Interstitial Pneumonia
- Tofacitinib
-
Ancona, Marche, ItalyOspedali Riuniti di Ancona
Apr 1, 2020